PORTON ADVANCED SOLUTIONS
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
PORTON ADVANCED SOLUTIONS
Industry:
Biotechnology Genetics Manufacturing Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Suzhou, Jiangsu, China
Country:
China
Website Url:
http://www.portonadvanced.com
Total Employee:
101+
Status:
Active
Contact:
512-88850572
Total Funding:
141.34 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps Content Delivery Network SSL By Default
Similar Organizations
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Altor BioScience
Altor BioScience researches and develops immunotherapeutic agents for the treatment of cancer, viral infections and autoimmune diseases.
Bluebird Bio
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
GenEdit
GenEdit develops next generation therapeutics for genetic diseases through safe and efficient CRISPR/Cas9 delivery.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Employees Featured
Sander van Deventer CSO @ Porton Advanced Solutions
CSO
2020-08-01
Oliver (Nianfeng) Ju CEO @ Porton Advanced Solutions
CEO
Investors List
China Merchants Group
China Merchants Group investment in Series B - Porton Advanced Solutions
HM Capital
HM Capital investment in Series B - Porton Advanced Solutions
China Merchants Health
China Merchants Health investment in Series B - Porton Advanced Solutions
Gortune Investment
Gortune Investment investment in Series B - Porton Advanced Solutions
China Merchants Securities
China Merchants Securities investment in Series B - Porton Advanced Solutions
Ruilin Investment
Ruilin Investment investment in Series B - Porton Advanced Solutions
SDICTK
SDICTK investment in Series B - Porton Advanced Solutions
CS Capital
CS Capital investment in Series B - Porton Advanced Solutions
Porton Pharma Solutions
Porton Pharma Solutions investment in Series B - Porton Advanced Solutions
Fosun Capital
Fosun Capital investment in Series B - Porton Advanced Solutions
Official Site Inspections
http://www.portonadvanced.com
- Host name: 43.130.149.77
- IP address: 43.130.149.77
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Porton Advanced Solutions"
Home - Porton Advanced
Porton Advanced: Your reliable CDMO partner in biotech, specializing in cell and gene therapy, mRNA, viral vectors, and plasmids with comprehensive GMP compliance.See details»
Porton Advanced | ATMP CDMO/CRO | LinkedIn
Porton Advanced is a Cell and Gene Therapy (CGT) CDMO/CRO. We provide end-to-end research grade, process development (PD), analytical development (AD), GMP …See details»
Porton Advanced Solutions - Crunchbase Company Profile
Porton Advanced Solutions provide end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.See details»
Porton Advanced - Overview, News & Similar companies - ZoomInfo
Jun 25, 2024 Explore Complete Organization Structure. Is Porton Advanced your ideal costumer? Let us give you the heads up on whether it's a good time to reach out ... Phone …See details»
Porton Advanced - Craft
Porton Advanced has 5 employees across 3 locations and $80 m in total funding,. See insights on Porton Advanced including office locations, competitors, revenue, financials, executives, …See details»
Porton Advanced - esgctcongress.com
9ed1dcc3-9fa5-42b2-ad26-45ecc3eb83e8. Porton Advanced is a leading CDMO specializing in cell, gene and nucleic acid therapies, offering comprehensive GMP CMC manufacturing …See details»
Porton Advanced Solutions, LLC - ASGCT's 28th Annual Meeting
May 17, 2025 PortonAdvanced.com provides CRO (research grade) and CDMO (GMP-like, GMP grade) for IVT mRNA, LNP, circRNA, Vector Cloning, Plasmid, Lentivirus Packaging, …See details»
About Us - Porton Advanced
Porton Advanced Solutions (Porton Advanced) is a CRO and CDMO. We provide end-to-end research, process development (PD), analytical development (AD), GMP manufacturing, and …See details»
Porton Advanced Announces Collaboration with Hualong …
SUZHOU, China, May 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy …See details»
Porton Advanced Announces Collaboration With Eureka …
Mar 19, 2025 <p>Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is …See details»
Contact us - Porton Advanced
Info@portonadvanced.com. Get Directions. CRO/CDMO Inquiry. Use the form below to reach out to us. We’ll get back to you as soon as possible. Cranbury Campus. Main Office 6 Cedarbrook …See details»
ASGCT 28th Annual Meeting
PortonAdvanced.com provides CRO (research grade) and CDMO (GMP-like, GMP grade) for IVT mRNA, LNP, circRNA, Vector Cloning, Plasmid, Lentivirus Packaging, Adeno-associated virus …See details»
Porton Advanced Announces a Strategic Partnership with BioMap, …
SUZHOU, China, Nov. 8, 2023 /PRNewswire/ -- On November 8, 2023, Porton Advanced announced the establishment of a strategic partnership with BioMap.BioMap will leverage …See details»
Porton Advanced Announces Collaboration with Hualong …
SUZHOU, China, May 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy …See details»
Porton Advanced Announces Collaboration with Eureka …
CRANBURY, N.J., March 19, 2025 /PRNewswire/ -- Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy …See details»
GMP Manufacturing/CDMO - Porton Advanced
As a recognized Contract Development and Manufacturing Organization (CDMO) in the field CGT, we are dedicated to delivering high-quality, Good Manufacturing Practice (GMP) compliant …See details»
Porton Advanced Announces Collaboration with Hualong …
SUZHOU, China, May 19, 2025 /PRNewswire/ — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy …See details»
Porton Advanced Announces Collaboration with Eureka …
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products …See details»
Process Development - Porton Advanced
Effective and efficient technology transfer is key to the success of CDMOs. At Porton Advanced, we have an established tech transfer process in which we take a stepwise approach, starting …See details»
Company News - Porton Advanced
Mar 26, 2025 Stay updated with the latest news from Porton Advanced. Explore insights, innovations, and developments in our industry to keep you informed and engaged.See details»